Correction to: Beta2-Agonist Doping Control and Optical Isomer Challenges

被引：0
|
作者：
Glenn A. Jacobson
J. Paul Fawcett
机构：
[1] University of Tasmania,School of Medicine
[2] University of Otago,School of Pharmacy
来源：
Sports Medicine | 2018年 / 48卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Page 1789, table 1, ‘Carmoterol’ row: The cell entry in the ‘Stereochemistry’ column, which previously read.
引用
收藏
页码：1523 / 1523
相关论文
共 50 条
  • [1] Beta2-Agonist Doping Control and Optical Isomer Challenges
    Jacobson, Glenn A.
    Fawcett, J. Paul
    [J]. SPORTS MEDICINE, 2016, 46 (12) : 1787 - 1795
  • [2] Beta2-Agonist Doping Control and Optical Isomer Challenges
    Glenn A. Jacobson
    J. Paul Fawcett
    [J]. Sports Medicine, 2016, 46 : 1787 - 1795
  • [3] Beta2-Agonist Doping Control and Optical Isomer Challenges (vol 46, pg 1787, 2016)
    Jacobson, Glenn A.
    Fawcett, J. Paul
    [J]. SPORTS MEDICINE, 2018, 48 (06) : 1523 - 1523
  • [4] Pitavastatin Potentiates Beta2-Agonist Induced Bronchodilation
    Schaible, N.
    Guo, R.
    Phalen, E.
    Chmiel, K.
    Ai, X.
    Bai, Y.
    Zeki, A. A.
    Krishnan, R.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [5] ICS/Beta2-Agonist Reliever Therapy in Adolescents and Adults With Asthma
    Beasley, Richard
    Cheng, Shih-Lung
    Lee, Kang-Yun
    Phuong, Phan Thu
    [J]. CHEST, 2023, 164 (05) : 1081 - 1083
  • [6] Beta2-agonist treatment of chronic obstructive pulmonary disease
    Siddall, Rhonda
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (10) : 551 - 551
  • [7] Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease
    Farne, Hugo A.
    Cates, Christopher J.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (10):
  • [8] Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease
    Karner, Charlotta
    Cates, Christopher J.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (04):
  • [9] A full beta2-agonist is more effective than a partial agonist in acute severe asthma
    Bag, R
    Zimmerman, J
    Sharafkhaneh, A
    Dickey, B
    Hanania, NA
    [J]. CHEST, 2004, 126 (04) : 722S - 722S
  • [10] AN INVESTIGATION OF THE CLINICAL IMPACT OF BETA2-AGONIST USE IN HEART FAILURE
    Bermingham, M.
    O'Callaghan, E.
    Dawkins, I
    Miwa, S.
    Samsudin, S.
    McDonald, K.
    Ledwidge, M.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2010, 179 : S388 - S388
12345